U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251933) titled 'A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries' on Nov. 19.
Brief Summary: HAE is a rare condition. It causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. This swelling happens because of a temporary leak in blood vessels but does not cause itching or hives. HAE is classified based on the amount of a protein in the blood called C1 inhibitor (C1-INH): HAE with normal C1-INH levels and HAE with limited or insufficient C1-INH levels (C1-INH deficiency). This study will concentrate on children with HAE C1-INH deficiency who have received Takhzyro (...